tiprankstipranks
Advertisement
Advertisement

LYRA Stock Latest News

Lyra Therapeutics Ends Major Office Sublease Agreement
Company AnnouncementsLyra Therapeutics Ends Major Office Sublease Agreement
4M ago
8K
LYRA
Lyra Therapeutics announces intention to file Form 25 for delisting from Nasdaq
PremiumThe Fly
Lyra Therapeutics announces intention to file Form 25 for delisting from Nasdaq
4M ago
LYRA
Lyra Therapeutics Streamlines Operations with Major Lease Terminations
PremiumCompany Announcements
Lyra Therapeutics Streamlines Operations with Major Lease Terminations
5M ago
8K
LYRA
Lyra Therapeutics Withdraws Nasdaq Appeal, Faces Imminent Delisting
PremiumCompany Announcements
Lyra Therapeutics Withdraws Nasdaq Appeal, Faces Imminent Delisting
5M ago
8K
LYRA
LYRA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LYRA Earnings this Week: How Will it Perform?
6M ago
LYRA
Lyra Therapeutics Faces Nasdaq Delisting After Becoming Shell
PremiumCompany AnnouncementsLyra Therapeutics Faces Nasdaq Delisting After Becoming Shell
7M ago
8K
LYRA
Lyra Therapeutics common stock to be delisted by Nasdaq
Premium
The Fly
Lyra Therapeutics common stock to be delisted by Nasdaq
7M ago
LYRA
One new option listing and option delistings on January 20th
Premium
The Fly
One new option listing and option delistings on January 20th
7M ago
CVM
TEF
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
7M ago
AMD
ANF
Why Is Lyra Therapeutics Stock (LYRA) Down Today?
PremiumMarket News
Why Is Lyra Therapeutics Stock (LYRA) Down Today?
7M ago
LYRA
Lyra Therapeutics Halts LYR-210, Cuts Workforce, Explores Options
PremiumCompany Announcements
Lyra Therapeutics Halts LYR-210, Cuts Workforce, Explores Options
7M ago
8K
LYRA
Lyra Therapeutics suspends further development of LYR-210
PremiumThe Fly
Lyra Therapeutics suspends further development of LYR-210
7M ago
LYRA
Cautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
PremiumRatingsCautious Hold Rating for Lyra Therapeutics Amid Strategic Focus and Financial Challenges
9M ago
LYRA
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
Premium
Company Announcements
Lyra Therapeutics Faces Financial Challenges Amid Clinical Setbacks
10M ago
LYRA
Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
Premium
The Fly
Lyra Therapeutics reports Q3 EPS ($3.38), consensus ($4.07)
10M ago
LYRA
LYRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
LYRA Upcoming Earnings Report: What to Expect?
10M ago
LYRA
Lyra Therapeutics announces clinical plan for LYR-210
PremiumThe Fly
Lyra Therapeutics announces clinical plan for LYR-210
11M ago
LYRA
Lyra Therapeutics Posts Corporate Presentation on LYR-210
PremiumCompany Announcements
Lyra Therapeutics Posts Corporate Presentation on LYR-210
12M ago
8K
LYRA
Lyra Therapeutics Receives Nasdaq Deficiency Letter
PremiumCompany Announcements
Lyra Therapeutics Receives Nasdaq Deficiency Letter
1y ago
8K
LYRA
Cautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
PremiumRatingsCautious Hold Rating on Lyra Therapeutics Amid Uncertainty in LYR-210’s Development and Approval Prospects
1y ago
LYRA
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
Premium
Company Announcements
Lyra Therapeutics Faces Manufacturing and Staffing Challenges Amid LYR-210 Production Shift
1y ago
LYRA
Lyra Therapeutics Reports Q2 2025 Financial Results
Premium
Company Announcements
Lyra Therapeutics Reports Q2 2025 Financial Results
1y ago
LYRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >